Gary Richmond
Pulmonary Disease · Fort Lauderdale, FLNPI 1255345963
Payments from drug & device makers
What this record shows
This record is dominated by consulting fees: $8,560 of the $12,018 with a category attached, or 71.2%. 17 manufacturers reported payments, led by Insmed, Inc. at 55.9% of the total. Reporting peaked in 2019 at $7,025 and has fallen 98.2% since, to $125 in 2023.
Across 92 payments — averaging $130.63 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Insmed, Inc.$7K
- Theratechnologies Inc.$3K
- Gilead$1K
- Viiv Healthcare Company$427
- Janssen Products, LP$287
- GSK$182
- plus $571 from 11 others
Across 340 payments — averaging $6836.63 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Viiv Healthcare Company$1.4M
- Gilead$680K
- Theratechnologies Inc.$217K
- GSK$8K
- Insmed, Inc.$8K
- Merck$7K
What the payments were for
- Consulting fees$8,56071%
- Travel & lodging$1,0619%
- Food & beverage$1,92716%
- Education$4704%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Insmed, Inc. | 14 | $6,722 |
| Theratechnologies Inc. | 1 | $2,500 |
| Gilead | 13 | $1,329 |
| Viiv Healthcare Company | 26 | $427 |
| Janssen Products, LP | 3 | $287 |
| GSK | 9 | $182 |
| Bayer | 1 | $125 |
| Actelion Pharmaceuticals US, Inc. | 2 | $98 |
| United Therapeutics Corporation | 6 | $65 |
| Boehringer Ingelheim | 3 | $64 |
| AstraZeneca | 4 | $56 |
| Amarin Pharma, Inc. | 2 | $44 |
| Philips North America LLC | 2 | $32 |
| Sebela Pharmaceuticals Inc. | 1 | $26 |
| Johnson & Johnson | 1 | $26 |
| Sunovion Pharmaceuticals Inc. | 3 | $22 |
| Mallinckrodt Enterprises LLC | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$12,018 in reported general payments places this provider in the 75th percentile of 953 pulmonary disease providers in Florida.
Other pulmonary disease in Fort Lauderdale
- Franck RahaghiWeston$1.2M
- Michael OttEglin Afb$909K
- Ali JiwaniOrlando$859K
- Anas HadehWeston$800K
- Jennifer FultonJacksonville$665K
- Ricardo Restrepo-JaramilloTampa$555K
- Mark RumbakTampa$528K
- Jose Soto SotoJacksonville$504K
- Javier Perez FernandezMiami$496K
- Domenick ReinaTampa$469K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.